A. Farfán Sedano-rekin lankidetzan egindako argitalpenak (3)

2023

  1. Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial

    Journal of Medical Virology, Vol. 95, Núm. 2

2022

  1. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients

    Journal of Infection

2021

  1. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

    Cancer